Caroline Nelson is a Dermatology physician affiliated with Yale University. OpenAlex indexes 94 publications with 1,964 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2 Church St S
New Haven, CT 065191717
Telephone
203-789-1249Registry record last updated 6 Aug 2019.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Pharmaceuticals, Inc.Program year20251 payment
- Regeneron Pharmaceuticals, Inc.Program year20241 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
24.1%Corticosteroid10.5%Triamcinolone Acetonide85%Halobetasol Propionate15%Part D<11 patientsInterleukin-4 Receptor alpha Antagonist8.7%Dupixent Pen78%Dupixent Syringe22%Part D<11 patients+ 2 more classes in this area
Anti-infectives
23.7%Azole Antifungal16.3%Ketoconazole100%Part D≥69 patientsLincosamide Antibacterial4.2%Clindamycin Phosphate100%Part D≥13 patients+ 2 more classes in this area
Sensory organs
22.1%Corticosteroid22.1%Hydrocortisone37%Clobetasol Propionate36%Betamethasone Dipropionate15%Betamethasone Diprop Augmented13%Part D≥43 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy
Journal for ImmunoTherapy of Cancer
2024 - Spatial transcriptomics reveals organized and distinct immune activation in cutaneous granulomatous disorders
Journal of Allergy and Clinical Immunology
2024 - Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis
Journal of the American Academy of Dermatology
2023 - Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management
Journal of the American Academy of Dermatology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
John Krystal, MD
Yale University
Lajos Pusztai, MD
Yale University
Lee Schwamm, MD
Yale University
Naftali Kaminski, MD
Yale University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”